Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer

INTRODUCTION: Combinations of 5-fluorouracil/leucovorin (5-FU/LV) with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are part of standard treatments for metastatic colorectal cancer (mCRC). For these molecules, the impact of a low relative dose intensity (RDI) on survival is not sufficiently known in...

Descripción completa

Detalles Bibliográficos
Autores principales: Blazevic, Ilfad, Vaillant, Willy, Basso, Maud, Salignon, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670185/
https://www.ncbi.nlm.nih.gov/pubmed/33235540
http://dx.doi.org/10.5114/wo.2020.100222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670185/
https://www.ncbi.nlm.nih.gov/pubmed/33235540
http://dx.doi.org/10.5114/wo.2020.100222

Ejemplares similares